|
Mechanismμ opioid receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date15 Feb 2019 |
100 Clinical Results associated with Aoxing Pharmaceutical Co., Inc.
0 Patents (Medical) associated with Aoxing Pharmaceutical Co., Inc.
100 Deals associated with Aoxing Pharmaceutical Co., Inc.
100 Translational Medicine associated with Aoxing Pharmaceutical Co., Inc.